WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60


Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
            Best Paper Award :
Dr. Muhammad Baqir MR Fakhrildin
Download Article: Click Here


Track Your Article



Dr. Vinod Manohar Chavan* and Dr. Manoj S. Nimbalkar


Background: Vyanga is one of the Raktapradoshaja roga, characterized by the presence of Niruja (painless) and Shyāvavarnan Mandn an la (brown/ blackish-blue patches) predominantly on face. On the basis of clinical features, Vyanga can be correlated with hyper pigmentation with special reference to Melasma/Chloasma. Melasma is a complex disorder involving various factors in its pathogenesis, identification of which will help us in developing better treatment options with more efficacy, less side effects and longer periods of remission. Newer compounds, especially botanical extracts and devicebased treatments are being developed and add to the list of options available for treatment. However, more randomized controlled trials are needed to evaluate their efficacy compared to the well- known treatments available. There is also need to define the role of combination therapy and design protocols to provide optimum results and prevent relapses.[1] In this article we are giving the holistic approach to treat the melasma with drugs like Elādi Lepa and Raktapācaka kvātha which have Rakta Prasādaka, Tvaka Prasādaka and ar akara properties helpful in the management of Vyanga (Melasma). This combination therapy pacifies prakupita Dośhas and help in Raktaśodhana (blood purification) ultimately helping skin to regain its normal complexion. Aim: To evaluate the efficacy of Elādi Lepa and Raktapācaka kvātha in Vyanga (Melasma). Materials and Methods: A total 3 middle aged female patients of Vyanga with no history of any major systemic illness were selected from outpatient department No. 15 of M. A. Podar Hospital Worli, Mumbai. In this study, the trial drugs used were Elādi Cur a for Lepa (tropical application) and Raktapācaka kvātha for oral administration for 21 days. And Elādi Curna for Lepa (tropical application) given for 3 months. Care taken to avoid Sun exposure. After 3 months effect of therapy on chief complaint i. e. brown/ blackish-blue pigmentation was relieved by 70%. Conclusion: The clinical study has shown that combined therapy of Elādi Curna for Lepa and Raktapācaka kvātha orally gives better results in Melasma/ Vyanga.

Keywords: El?di Curna, Raktap?caka kv?tha, Melasma, hyper-pigmentation, melasma, Vyanga.

[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More